Should women at high risk of neural tube defect have an amniocentesis?

As part of an investigation into the practical problems of a maternal serum alphafetoprotein (AFP) neural tube defect (NTD) screening programme carried out in Mid Glamorgan, South Wales, between 1977 and 1979, obstetricians were recommended to refer women with high risk pregnancies directly for counselling, high resolution ultrasonography, and amniocentesis without first carrying out serum screening. Out of 15 687 pregnant women one-third attended too late to be screened. A total of 637 was classed as high risk, mostly at greater risk than 1 in 50 because of a previously affected pregnancy or an affected close relative. Compliance with recommended procedure was relatively low as many were screened. There were 10 pregnancies with a recurrence of NTD, of which one was not tested at all, two were not detected (one closed meningocele and one closed iniencephalic), and seven were detected and the pregnancies terminated. All the latter, as well as the iniencephalic, would have been detected from a serum AFP determination and a high resolution ultrasound scan alone. It is concluded that these investigations are sufficient for high risk pregnancies and that amniocentesis is not really cost effective or necessary unless either of these investigations is abnormal. As numbers in this study were small it is suggested that these conclusions should be tested in a larger study.

[1]  G. Elder,et al.  Can we afford screening for neural tube defects? The South Wales experience. , 1985, British medical journal.

[2]  K. Laurence,et al.  Anxiety during a crisis: emotional effects of screening for neural tube defects. , 1984, Journal of psychosomatic research.

[3]  K. Laurence,et al.  DIAGNOSTIC EFFECTIVENESS OF ULTRASOUND IN DETECTION OF NEURAL TUBE DEFECT The South Wales Experience of 2509 Scans (1977-1982) in High-risk Mothers , 1983, The Lancet.

[4]  G. Elder,et al.  THE EFFICACY OF A SERUM SCREENING SERVICE FOR NEURAL-TUBE DEFECTS: THE SOUTH WALES EXPERIENCE , 1983, The Lancet.

[5]  K. Laurence,et al.  Screening for neural‐tube defects and maternal anxiety , 1982, British journal of obstetrics and gynaecology.

[6]  A. Read,et al.  New uncertainties in prenatal screening for neural tube defect. , 1981, British medical journal.

[7]  K. Laurence,et al.  The effect of the introduction of prenatal diagnosis on the reproductive history of women at increased risk from neural tube defects , 1981, Prenatal diagnosis.

[8]  W. P. Ennis,et al.  Precision in estimating gestational age and its influence on sensitivity of alphafetoprotein screening. , 1979, British medical journal.

[9]  J. Brooks-Gunn MATERNAL SERUM-ALPHA-FETOPROTEIN MEASUREMENT IN ANTENATAL SCREENING FOR ANENCEPHALY AND SPINA BIFIDA IN EARLY PREGNANCY: , 1978 .

[10]  N J Wald,et al.  MATERNAL SERUM-ALPHA-FETOPROTEIN MEASUREMENT IN ANTENATAL SCREENING FOR ANENCEPHALY AND SPINA BIFIDA IN EARLY PREGNANCY Report of U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects , 1977, The Lancet.

[11]  C. Carter,et al.  A family study of major central nervous system malformations in South Wales. , 1968, Journal of medical genetics.